Many pharmaceutical companies listed strategic objectives for 2024 that included solving for health inequities, clearly positioned within pillars that focused on improving or increasing the value of their products. For one reason or another, many of those objectives were set aside as planning commenced in the new year, leaving this crushing challenge to our society unaddressed.
Tag Archive for: discrimination
A U.S. appeals court upheld the dismissal of a lawsuit by a conservative group opposed to diversity initiatives in medicine that challenged a Pfizer fellowship program designed to boost the pipeline of Black, Latino, and Native American people leadership positions at the drugmaker.
The global response to AIDS is “under threat” because of an unprecedented backlash against human rights that is stigmatizing the groups most at risk of HIV infection, the head of the United Nations AIDS programme has warned.
A federal judge tossed a lawsuit by a group of medical professionals alleging a fellowship program established by Pfizer to improve diversity within its higher ranks discriminates against white and Asian-American applicants.
One of the advantages of leveraging behavioral science in healthcare marketing is that it provides marketers with powerful tools to do what we do best: solve problems. Once we are able to identify the unique behavioral barriers at play, the science leads us toward solutions that are likely to be successful in addressing them. But what happens when we are faced with behavioral challenges that are not so clearly solvable?
A federal judge in Texas ruled on Friday that President Joe Biden’s administration had wrongly interpreted an Obamacare provision as barring health care providers from discriminating against gay and transgender people.
A group of medical professionals that advocates against “radical, divisive, and discriminatory ideology” in healthcare sued Pfizer Inc. on Thursday, saying the drugmaker runs a fellowship that illegally excludes white and Asian-American applicants.
While preventive care is vital to the well-being of all types of patients, members of the lesbian, gay, bisexual, transgender and queer and/or questioning community face unique barriers that impact their preventive health awareness and access – setting many of them up for poorer overall health outcomes and even impacting their trust in pharma.
